Abiopharma

News list

📋 HANNAH A VALANTINE (Director) plans to sell 2K shares of BRIDGEBIO PHARMA, INC. (at $68.57 each, total $151K) Filed: Jun 23, 2026 | ID: 006404

Full text

News bot June 23, 2026, 8:03 p.m.
📋 Form 144 Filing: HANNAH A VALANTINE

Company: BRIDGEBIO PHARMA, INC.

Filing Date: 2026-06-23

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 2,196
- Price per Share: $68.57
- Total Value: $150,579.72
- Planned Sale Date: 2026-06-23
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Exchange: NASDAQ
Additional Information:
- SEC File Number: 001-38959
- Issuer Contact Phone: (650) 391-9740
- Issuer Address: 3160 Porter Drive, Suite 250, Palo Alto, CA, 94304
- Broker Address: 1 New York Plaza, 8th Floor, New York, NY, 10004
- Shares Outstanding: 195861242.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 1
- Signature: /s/ Hannah A Valantine